✦ LIBER ✦

Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients

✍ Scribed by G. Visani; C. Finelli; U. Castelli; M. C. Petti; P. Ricci; N. Vianelli; L. Gianni; E. Zuffa; M. A. Aloe Spiriti; R. Latagliata; S. Pileri; U. Magrini; L. Gugliotta; E. Morra; C. Bernasconi; F. Mandelli; S. Tura

Book ID: 114712037
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 528 KB
Volume: 75
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1990.tb02609.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy and antiangiogenic act

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study

✍ Piccaluga, P P; Visani, G; Pileri, S A; Ascani, S; Grafone, T; Isidori, A; Malag 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 199 KB

Peripheral blood CD34 count in myelofibr

Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients

✍ Brijesh Arora; Shireen Sirhan; James D. Hoyer; Ruben A. Mesa; Ayalew Tefferi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Analysis of the androgen response of 23

Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: The value of chromosomal studies in predicting response and survival

✍ Emmanuel C. Besa; Peter C. Nowell; Nancy L. Geller; Frank H. Gardner 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

The responses of 23 patients with agnogenic myeloid metaplasia (AMM) to androgen therapy were studied. Various clinical and laboratory parameters were analyzed for their value in determining response to therapy and length of survival. Fifty-seven percent of patients responded, a s determined by a su

Efficacy and tolerability of danazol as

Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients

✍ Francisco Cervantes; Alberto Alvarez-Larrán; Abel Domingo; Eduardo Arellano-Rodr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Chronic idiopathic myelofibrosis: progno

Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages

✍ A. Kreft; M. Weiß; B. Wiese; H. Choritz; T. Buhr; G. Büsche; A. Georgii 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 623 KB

Serologic determinants of survival in pa

Serologic determinants of survival in patients with head and neck cancer: Validating a clinical prediction model

✍ Daniel D. Lydiatt; Howard E. Savage; Gary L. Clayman; Dory Sample; Stimson P. Sc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB